Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
22.5M
-
Shares change
-
+4.72M
-
Total reported value, excl. options
-
$119M
-
Value change
-
+$25.3M
-
Put/Call ratio
-
0.12
-
Number of buys
-
71
-
Number of sells
-
-31
-
Price
-
$5.31
Significant Holders of Niagen Bioscience, Inc. - COM NEW (NAGE) as of Q4 2024
134 filings reported holding NAGE - Niagen Bioscience, Inc. - COM NEW as of Q4 2024.
Niagen Bioscience, Inc. - COM NEW (NAGE) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.5M shares
.
Largest 10 shareholders include BlackRock, Inc. (3.61M shares), VANGUARD GROUP INC (3.39M shares), Tieton Capital Management, LLC (2.59M shares), ICONIQ Capital, LLC (1.3M shares), GEODE CAPITAL MANAGEMENT, LLC (1.15M shares), D. E. Shaw & Co., Inc. (1.01M shares), STATE STREET CORP (915K shares), RENAISSANCE TECHNOLOGIES LLC (713K shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (663K shares), and Connor, Clark & Lunn Investment Management Ltd. (506K shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.